COLLEGIUM PHARMACEUTICAL INC's ticker is COLL and the CUSIP is 19459J104. A total of 197 filers reported holding COLLEGIUM PHARMACEUTICAL INC in Q1 2023. The put-call ratio across all filers is 1.63 and the average weighting 0.1%.
Links
Filings
- All filings
- Annual reports (10-K)
- Quarterly reports (10-Q)
- Insider transactions
- Shareholder votes
- Significant ownership
- Events
EDGAR links
External links
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $9,029,847 | +3.4% | 404,020 | -0.6% | 0.00% | 0.0% |
| Q2 2023 | $8,734,740 | -6.2% | 406,456 | +4.7% | 0.00% | 0.0% |
| Q1 2023 | $9,314,261 | +4.2% | 388,256 | +0.8% | 0.00% | 0.0% |
| Q4 2022 | $8,936,431 | +44.3% | 385,191 | -0.3% | 0.00% | +100.0% |
| Q3 2022 | $6,191,000 | -8.6% | 386,455 | +1.1% | 0.00% | 0.0% |
| Q2 2022 | $6,776,000 | -15.2% | 382,402 | -2.6% | 0.00% | 0.0% |
| Q1 2022 | $7,992,000 | +5.1% | 392,509 | -3.6% | 0.00% | 0.0% |
| Q4 2021 | $7,607,000 | -10.9% | 407,213 | -5.8% | 0.00% | -50.0% |
| Q3 2021 | $8,536,000 | -16.5% | 432,385 | +0.0% | 0.00% | 0.0% |
| Q2 2021 | $10,221,000 | -1.6% | 432,362 | -1.4% | 0.00% | 0.0% |
| Q1 2021 | $10,390,000 | +13.5% | 438,421 | -4.1% | 0.00% | 0.0% |
| Q4 2020 | $9,153,000 | -7.8% | 456,953 | -4.2% | 0.00% | 0.0% |
| Q3 2020 | $9,930,000 | +14.8% | 476,931 | -3.5% | 0.00% | 0.0% |
| Q2 2020 | $8,652,000 | +24.6% | 494,451 | +16.3% | 0.00% | 0.0% |
| Q1 2020 | $6,945,000 | -19.1% | 425,288 | +2.0% | 0.00% | 0.0% |
| Q4 2019 | $8,583,000 | +54.7% | 416,977 | -13.7% | 0.00% | +100.0% |
| Q3 2019 | $5,548,000 | +8.9% | 483,318 | +24.7% | 0.00% | 0.0% |
| Q2 2019 | $5,095,000 | -12.2% | 387,440 | +1.1% | 0.00% | 0.0% |
| Q1 2019 | $5,803,000 | -11.8% | 383,239 | -0.0% | 0.00% | -50.0% |
| Q4 2018 | $6,582,000 | -4.2% | 383,289 | -17.8% | 0.00% | 0.0% |
| Q3 2018 | $6,871,000 | -45.3% | 466,179 | -11.5% | 0.00% | -33.3% |
| Q2 2018 | $12,557,000 | +66.6% | 526,499 | +78.5% | 0.00% | +50.0% |
| Q1 2018 | $7,538,000 | +42.0% | 295,036 | +2.6% | 0.00% | +100.0% |
| Q4 2017 | $5,307,000 | +84.3% | 287,483 | +4.7% | 0.00% | 0.0% |
| Q3 2017 | $2,879,000 | -17.3% | 274,508 | -1.4% | 0.00% | 0.0% |
| Q2 2017 | $3,483,000 | +58.2% | 278,425 | +27.2% | 0.00% | 0.0% |
| Q1 2017 | $2,202,000 | -34.4% | 218,846 | +1.6% | 0.00% | 0.0% |
| Q4 2016 | $3,355,000 | -1.3% | 215,463 | +22.0% | 0.00% | 0.0% |
| Q3 2016 | $3,400,000 | +67.3% | 176,547 | +3.0% | 0.00% | 0.0% |
| Q2 2016 | $2,032,000 | +12.6% | 171,468 | +72.5% | 0.00% | 0.0% |
| Q1 2016 | $1,804,000 | -22.0% | 99,402 | +18.1% | 0.00% | 0.0% |
| Q4 2015 | $2,313,000 | +54.6% | 84,135 | +24.3% | 0.00% | – |
| Q3 2015 | $1,496,000 | – | 67,662 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Rubric Capital Management LP | 2,606,500 | $51,452,000 | 1.44% |
| Camber Capital Management LP | 2,000,000 | $39,480,000 | 1.22% |
| Eventide Asset Management | 2,629,593 | $51,908,000 | 0.68% |
| GREAT POINT PARTNERS LLC | 121,342 | $2,395,000 | 0.56% |
| RICE HALL JAMES & ASSOCIATES, LLC | 753,038 | $14,865,000 | 0.55% |
| Values First Advisors, Inc. | 41,773 | $825,000 | 0.53% |
| CLARK ESTATES INC/NY | 183,800 | $3,628,000 | 0.52% |
| EMERALD MUTUAL FUND ADVISERS TRUST | 710,398 | $14,023,000 | 0.48% |
| EMERALD ADVISERS, LLC | 590,256 | $11,652,000 | 0.42% |
| ACORN FINANCIAL ADVISORY SERVICES INC /ADV | 68,812 | $1,358,000 | 0.42% |